Navigation Links
Biomet® Ankle Arthrodesis Nail

ProductsBiomet® Ankle Arthrodesis Nail
Company Biomet Orthopedics, Inc
Item Biomet® Ankle Arthrodesis Nail
Features 
  • The strength and biocompatibility of titanium alloy
  • Lateral to medial transfixation locking screws
  • A load sharing fixation device that affords torsional rigidity and better calcaneal purchase through the posterior to anterior transcalcaneal locking screw
  • The option for compression with a unique nail-mounted compression device
  • Precise, reproducible instrumentation with nail-mounted targeting for the proximal and distal screws
  • For tibiotalocalcaneal or pantalar ankle fusion
  • A posterior to anterior screw provides 40% greater torsional rigidity than lateral to medial screws alone 1
  • Proven clinical results
    • Description The Biomet Ankle Arthrodesis Nail is ideally suited for tibiotalocalcaneal fusion indications. This second-generation nail affords rigid, load sharing fixation that incorporates a simple nail-mounted, in-line method of compression across the arthrodesis sites.
    Info Biomet Orthopedics, Inc
    Customer Service: (800) 348-9500
    Web site: http://www.biomet.com

    Related medicine products :

    1. Biomet® Arthrodesis Nail
    2. Buechel-Pappas™ Total Ankle System
    3. Agility Total Ankle System
    4. Ankle Arthrodesis Nail
    5. True/Fix Ankle Fusion Nail System
    6. Guhl Non-Invasive Ankle Distractor System
    7. Ankle Cryo/Cuff™
    8. Pediatric Ankle Cryo/Cuff™
    9. Air-Stirrup® Ankle Brace
    10. QualCare™ Compression Ankle Support
    11. Allsport Ankle Ortho II
    The Vitatron Excellence + lead series are endocardial leads providing excellent handling and optimal pacing characteristics.
    The family of Passive Plus DX passive-fixation leads features a 5 mm tip, designed to increase current density and pacing impedance, and a tine fixation, offering versatility and security in lead pla
    Selute Picotip Atrial-J steroid eluting passive fixation lead
    The VascoTip J 9/60 PU is a unipolar tined, J-preformed permanent pacing lead. Due to advanced technology, VascoTip J 9/60 PU M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm),
    Medicine Products:
    (Date:7/25/2008)...ormer McKesson Corporation Executive, Robert J. Re...ewswire/ -- Aethon Inc.,( http://www.aethon.com ),...ital supply chain logistics, today announced that ...Vice President -- Chief Financial Officer., Reill... Manager for,McKesson Corporation,s Specialty Phar...
    (Date:7/25/2008)... HOUSTON, July 25 /PRNewswire/ -- The Elekta Fami... cancer treatment solutions at the 2008,American A... meeting,demonstrating how the joint forces of El...diation therapy planning and delivery solutions th...tter experience for,patients, as well as enhance c...
    (Date:7/25/2008)... CARLSBAD, Calif., July 25 /PRNewswire/ -- AutoGe...egistration statement on Form S-1 with the,Securit...ed initial public,offering of shares of its common... offered, all of which are expected to be offered ... offering, have not yet been,determined., J.P. Mo...
    (Date:7/25/2008)...turday can be toughest for those trying to drop po...ealthDay News) -- Anyone who has avoided Monday mo...ends are not a dieter,s friend. , Now, research...ts about weekends being their undoing: Most people...ing to lose weight. , "Weekend indulgences can ...
    Breaking Medicine News(10 mins):Health News:Aethon, Inc. Names New Chief Financial Officer 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 3Health News:AutoGenomics, Inc. Files Registration Statement for Initial Public Offering 2Health News:Weekends Tough on the Diet 2Health News:Weekends Tough on the Diet 3
    ... has confirmed that 22 organizations have joined h...igma and discrimination// associated with AIDS in ...lth and labor companies, the employers group has b...anies that believe in instituting policies to comb...
    ...F) suggested that people with advanced heart disea...der than their real age.// In a study conduct...examined tissues from heart bypass and transplant ...y cells age. They found that the artery cells d...
    ...gow University, English cider apples have high lev...ion against stroke, heart// disease and cancer. T...n keeping the doctor away!The scientists plan to t...nteers to drink a pint a day . The volunteers will...
    ...n genome to date linked to the identifiction of pe...en completed by researchers at// the Molecular Neu... Abuse (NIDA), National Institutes of Health. This...hnology has been used to comprehensively identify ...
    Other Medicine News:Health News:Study to Identify People at Risk of Alcoholism 2Health News:Study to Identify People at Risk of Alcoholism 3
    (Date:7/23/2008)...ork with Protein Therapeutics that Modul...BRIDGE, Mass., July 23 /- Taligen The...corporate growth plan with the,appointment of Abbi...the,establishment of its headquarters in Cambridge..., a co-founder of the company who remains presiden...
    (Date:7/22/2008)...ment Plan Completed Successfully, DUBLIN, Ireland...tion,plc (NASDAQ: AMRN ) today announced that the...ood and Drug Administration (FDA) to discuss the,C... of,hypertriglyceridemia. Following these discussi...101 in hypertriglyceridemia., Dr. Declan Doogan, ...
    (Date:7/22/2008)... 22 /- Hyperion,Therapeutics, Inc. to...ment,in its Phase 1/2 clinical trial to evaluate t...ects of HPN-100 (formally called GT4P) versus,BUPH...rea cycle disorders,(UCD). The company plans to an...his year., (Logo: http://www.newscom.com/cgi-bin...
    (Date:7/22/2008)...enetic Risk Based on Clinical Data, Preventive ...als, WALTHAM, Mass., July 22 /PRNewswire-FirstCal...day announced the launch of an enhanced test repor... Heart Health Genetic Test.,The test is currently ...lth,Genetic Test by Quixtar/Amway. The new report ...
    Breaking Medicine Technology:Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 2Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 3Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 2Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 3Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 2Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 3Interleukin Genetics Launches Enhanced Heart Health Genetic Test Report Format 2Interleukin Genetics Launches Enhanced Heart Health Genetic Test Report Format 3Healthcare M 26A Activity on the Rise 9649 1Healthcare M 26A Activity on the Rise 9649 2BD Announces Webcast of Annual Meeting of Shareholders 9646 1New Research Shows Nutrition Programs Targeting Pregnancy and First 24 Months of Life Dramatically Improve Child Survival and Overall Health 9643 1New Research Shows Nutrition Programs Targeting Pregnancy and First 24 Months of Life Dramatically Improve Child Survival and Overall Health 9643 2New Research Shows Nutrition Programs Targeting Pregnancy and First 24 Months of Life Dramatically Improve Child Survival and Overall Health 9643 3New Research Shows Nutrition Programs Targeting Pregnancy and First 24 Months of Life Dramatically Improve Child Survival and Overall Health 9643 4New Research Shows Nutrition Programs Targeting Pregnancy and First 24 Months of Life Dramatically Improve Child Survival and Overall Health 9643 5New Research Shows Nutrition Programs Targeting Pregnancy and First 24 Months of Life Dramatically Improve Child Survival and Overall Health 9643 6OMI Medical Imaging Inc and Affiliated Companies File Chapter 11 Reorganization 9640 1OMI Medical Imaging Inc and Affiliated Companies File Chapter 11 Reorganization 9640 2
    ...DIEGO--(BUSINESS WIRE)--Mar 14, 2007 - Sequenom, I...RAY(R) technology and,iPLEX(TM) assay were used by...stitutions and, in independent studies, significan... and drug-resistant,malaria. Results from several ...ed peer-reviewed journals as follows:, -- In "High...
    ...LADELPHIA, March 15, 2007-- The cause of one notor...to treat the ongoing,threat of another childhood d...ncer Research, researchers from Stony Brook Univer...-- form of poliovirus,is effective in obliterating...had been previously vaccinated against the virus. ...
    Other Medicine Technology:Use of Sequenom's MassARRAY System Leads to Significant Scientific,Advances in Understanding Cancer, Diabetes and Drug-Resistant,Malaria 2Use of Sequenom's MassARRAY System Leads to Significant Scientific,Advances in Understanding Cancer, Diabetes and Drug-Resistant,Malaria 3Researchers Use Poliovirus to Destroy Neuroblastoma Tumors in Mice 2Researchers Use Poliovirus to Destroy Neuroblastoma Tumors in Mice 3Researchers Use Poliovirus to Destroy Neuroblastoma Tumors in Mice 4